Day Traders, Penny Stocks, Stock Options, Futures and Forex

YUCAIPA, Calif., Oct. 14, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading Global Medical Device manufacturer focused in the $4 billion Respiratory Market for the growing ageing and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that the company has received a proposal from a leading manufacturer to help reduce production costs and material costs by 50% for the manufacture of the Oxyview and the Oxyview Nasal Cannula.


Related Quotes
Symbol Price Change
IGNT.PK 0.0034 0.0000


{"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}
As a part of improving product quality in large production, and reducing material and production costs to be more competitive in the respiratory marketplace, the company has received a proposal from a leading respiratory equipment manufacturer based in Pomona-California. The company CEO, and some of the management staff received a proposal on Wednesday last week to manufacture both the Oxyview and the Oxyview Nasal Cannula at 50% of the original costs from its current manufacturer and supplier. On Friday last week, they had a meeting in Pomona with the new manufacturer to discuss the new manufacturing and distribution of Oxyview and the new Oxyview Nasal Cannula.



"Now that we are selling our respiratory products, and sales have escalated, we must reduce our cost of goods sold in order to increase our profit margins and decrease the costs to our dealers and buyers. This change will give the company a stronger foot-hold in the market. We have a proprietary product and there is nothing in the marketplace that can compete with our device. We have gained support for all sectors of our industry, inclusive of leading respiratory equipment manufacturers, clinical foundations and more important, our shareholders," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

congrates to everyone on ignt poss news coming out at close

congrates to everyone who rode with ignt yesterday , they have been good to me so im going with them again today got a great feeling ,

11.8% increase yesterday

macd line was stable all week

expecting a big jump in the rsi as well as the price

by later in the morning pre buys will be going crazy

Ingen Technologies brings over 20 years of experience and dedication to the design and support of medical devices, Ingen has helped many medical professionals meet clinical and economic objectives.

Ingen has developed medical products that provide a valuable benefit to the patient and cost savings to the insurance companies, Medicare and essentially the tax payer. The medical products provide a focus for the ever-increasing elderly population. These products are superior to any of our competition and they allow for effective medical product availability to seniors.
Ingen’s Mission: Our Commitment to Customers

Ingen is committed to meeting the needs of our customers through ongoing product innovation and support. Ingen distributes its products through a national distributor network domestically and in Canada, Asia and European Communities. Ingen’s commitment to customers continues beyond the sale of our product.
The Beginning

Ingen, originally a privately owned company founded for the purpose of providing medical solutions for our growing healthcare market, is now a publicly traded company and growing medical device manufacturer. In 1999, Ingen founders invested several millions of dollars in the research and development of state-of-the-art respiratory monitoring devices, with a focus on helping patients and preventing unnecessary costs to the healthcare system. With multiple patents, FDA classification and certifications, Ingen is the largest manufacturer of gravity-independent in-line oxygen flow meters, meeting the demand of the growing patient population and service providers. Our products are manufactured in the USA.
Our Capabilities

We are proud of our capabilities in gas flow-meter technology and wireless digital data transfer of gas flow rate processing. Ingen is the first company to patent and develop transducers that detect oxygen flow rate and provide data transfer. This has revolutionized the oxygen therapy market providing user friendly solutions in monitoring oxygen levels and oxygen delivery systems.

Ingen Technologies, Inc. introduces Oxyview® , the World's First Patient In-Line Oxygen Flow-Meter. Another innovative respiratory product manufactured in the USA by Ingen Technologies; providing more confidence and assurance to patients using oxygen. Oxyview® is reusable, requires no batteries, works all the time in any position with all liquid or gas O2 systems, and easily installs anywhere below the cannula nearest the patient where oxygen flow matters the most. Oxygen suppliers and patients will appreciate that Oxyview® prevents many unnecessary service calls.

Ingen Technologies is now offering a quality organic health supplement for patients using home oxygen therapy, and also to anyone else who is interested in healthy life styles. As a part of wellness, we are now offering the new Poga Moonga products. Poga Moonga includes a substance referred to as Moringa, and is extracted from the Moringa Tree. Ingen provides a drink or capsule that is efficiently absorbed by the bodies metabolism.

One bottle is 25.35 Ounces. The instructions say to take 1-3 oz daily, therefore one bottle should last between 8-25 days. A purchase includes 4 bottles or 1-3 months supply depending upon use.
Author Sanford Holst in “Moringa, Nature’s Medicine Cabinet,” writes,

"...it is said the Moringa tree prevent 300 diseases. Ancient Roman, Greek and Egyptian civilizations used...the (Moringa Tree)...It is best known as an excellent source of nutrition and a natural energy booster. Loaded with nutrients, vitamins and amino acids, it replenishes your body and provides what you need to through a hectic weekday or active weekend..." It produces long-lasting energy without hyperactivity...a nerve system at rest...a blood system not under pressure...a gland and hormone system in balance."
An L.A. Times article said,

Scientifically speaking, Moringa sounds like magic. It can rebuild weak bones, enrich anemic blood and enable a malnourished mother to nurse her staving baby. Doctors use it to treat diabetes in West Africa and high blood pressure in India...And, it’s not only good for you, it’s delicious." Mark Fritz, L.A. Times.

Perhaps the most remarkable thing about the Moringa is that it has such incredible health benefits over a wide-range of health issues. Here are but a few:

* NUTRITION AND ENERGY BOOST
While most people notice an energy boost right away, the nutritional results with undernourished people is staggering.
* DETOXIFICATION
In vitro studies show the Moringa’s ability to remove putrid waste from water. This is important for the planet. Over 6 million children are believed to die each year from infections caused by unclean water. It helps our bodies detoxify in much the same way.
* ANTIBIOTIC
Moringa works as a gentle, natural antibiotic,
See Eilert, U.,B. Wolters and A. Nahrstedt. “The antibiotic principle of seeds of Moringa oleifera and Moringa stenopetala.” Journal of Medicinal Plant Research, 42, pp 55-61. 1981
* SKIN TREATMENT
And, like Aloe Vera, Moringa is believed to have great healing benefits for the skin. Most of the research is on topical applications, but the healing properties would extend to the body itself.
* ANTI-INFLAMMATORY
Indian traditional medicines have long used the Moringa in treating the body’s inflammation. See, Udupa, S.L., A.L. Udupa and D.R. Kulkarni, “Studies on the anti-inflammatory and wound healing properties of Moringa oleifera and Aegle marmelos. Fitoterapia 65(2) pp 119-123.
* ULCERS
The anti-ulcer effect of Moringa was reported in 1995 in Phytotherapy research. An extract was taken from dried leaves and showed an impressive ability to heal ulcers in lab animals. Holst, p17.
* DIABETES
An extract from the Moringa leaf has been shown to be effective in lowering blood sugar levels with a space of 3 hours. Holst, pp17-18.
* SLEEP
The leaf of the Moringa has been shown to aid in a calmer nervous system providing an improving in sleep. Holst, p18

In short some studies have proved Moringa leaves effective for treating,

* Blood pressure
* Diabetes
* Colitis and Diarrhea
* Used as a diuretic
* Headache
* Glandular swelling
* Skin antiseptic
* Fevers

Seeds are used for,

* Fevers
* Tumors
* Rheumatism
* Skin diseases
* Prostate and bladder issues

Leadership

Scott R. Sand




Chief Executive Officer and Chairman of the Board

Thomas J. Neavitt




Chief Financial Officer

J.R. Marple




Senior Accountant

Ron Mitchell




Certified Public Accountant

William Denney




Auditor- Child, Van Wagoner and Bradshaw LLC

Christopher A. Wirth




Chief Operations Officer & Director

Bradley C. Klearman




Director and EVP of Sales & Distribution

David Wald




Office Manager

John Finazzo, MD




Director and Chairman of the Medical Advisory Board

Stephen O’Hara, MD




Director and Member of the Medical Advisory Board

Peter Wilke




Attorney

Donn Harms




Patent Attorney

Robert H. Sand




Chief Manufacturing Engineer

Richard Campbell




Product Design & Engineering

IGNT a leading global Medical Device Manufacturer for the Oxyview Nasal Cannula, focused on the $4B Respiratory market for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today the introduction of the new Oxyview Pulse Oximeter. Great news!! Company will make run! IMO

Get 193% gains right here.


Super Stock Picker

Ingen Introduces Oxyview Products at ATS
Effective Advertising and Product Branding Scheduled for 2010

.Companies:Ingen Technologies, Inc..Press Release Source: Ingen Technologies, Inc. On Thursday January 14, 2010, 8:15 am

YUCAIPA, Calif., Jan. 14, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced the introduction of their Oxyview product line at the 2010 ATS International Conference on May 14-19, 2010 in New Orleans, Louisiana.



The American Thoracic Society (ATS) is committed to disseminating the latest advances, nationally and internationally, in the fields of lung disease, sleep disorders and critical care medicine. The annual International Conference has become the premier, international forum for physicians and scientists who work in pulmonary, critical care, and sleep medicine.



The company will reach 13,000 pulmonologists through the advertising in Medco Forum's ATS issue that is scheduled to be released on May 1, 2010. Medco Forum will also host the Oxyview advertising on their website.



The company now advertises in several major publications, inclusive of COPD Digest, Today's Senior Magazine and Medco Forum.



Throughout 2009, Ingen showcased their newest medical respiratory equipment at several conventions, including the MEDICA convention in Germany and the American Association of Respiratory Care (AARC) in San Antonio, Texas. These showings captured the attention of many distributors who were interested in Oxyview, taking Ingen a step closer to achieving international distribution and a growing presence in the hospital and therapy markets.



As the number of respiratory diseases continue to increase, so too does the number of patients requiring oxygen support. That's why Ingen expects to see more demand for the Oxyview Nasal Cannula and the Oxyview Pulse Oximeter in 2010 and the coming years. The company expects to acquire more distributors in the United States and the developing markets of Asia, Canada, Australia and Europe.

Ingen Introduces Oxyview Products at ATS
Effective Advertising and Product Branding Scheduled for 2010


Buzz up! 0 Print..Companies:Ingen Technologies, Inc..Related Quotes
Symbol Price Change
IGNT.PK 0.0023 0.0000


{"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""} Press Release Source: Ingen Technologies, Inc. On Thursday January 14, 2010, 8:15 am

YUCAIPA, Calif., Jan. 14, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced the introduction of their Oxyview product line at the 2010 ATS International Conference on May 14-19, 2010 in New Orleans, Louisiana.



The American Thoracic Society (ATS) is committed to disseminating the latest advances, nationally and internationally, in the fields of lung disease, sleep disorders and critical care medicine. The annual International Conference has become the premier, international forum for physicians and scientists who work in pulmonary, critical care, and sleep medicine.



The company will reach 13,000 pulmonologists through the advertising in Medco Forum's ATS issue that is scheduled to be released on May 1, 2010. Medco Forum will also host the Oxyview advertising on their website.



The company now advertises in several major publications, inclusive of COPD Digest, Today's Senior Magazine and Medco Forum.



Throughout 2009, Ingen showcased their newest medical respiratory equipment at several conventions, including the MEDICA convention in Germany and the American Association of Respiratory Care (AARC) in San Antonio, Texas. These showings captured the attention of many distributors who were interested in Oxyview, taking Ingen a step closer to achieving international distribution and a growing presence in the hospital and therapy markets.



As the number of respiratory diseases continue to increase, so too does the number of patients requiring oxygen support. That's why Ingen expects to see more demand for the Oxyview Nasal Cannula and the Oxyview Pulse Oximeter in 2010 and the coming years. The company expects to acquire more distributors in the United States and the developing markets of Asia, Canada, Australia and Europe.



ATS 2010 * New Orleans



Medco Forum



Ingen Technologies,Inc. - Home

NEWS 2010 Looks to be a Big Year for Ingen Technologies


The Company Expects More Distributors, in the U.S. and Abroad, to Pick Up Oxyview
YUCAIPA, Calif., Jan 14, 2010 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading manufacturer of respiratory medical devices, recently announced that they will engage Medical Strategies International (MSI) to increase sales of the Oxyview product line through GPO contracts.
MSI specializes in helping companies increase sales through Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs), and Equipment Planners. Medical Strategies International (MSI) is a strategic business-consulting firm focused on the Medical industry. MSI's Executive Team is highly trained healthcare professionals with over 70 years experience in the Sales, Marketing, Government and Corporate Account Management of medical products and services. Our goal is to assist companies that manufacture or distribute products and services to the Hospital/Physician market and help them increase sales through the extremely important arena of Healthcare Group Purchasing Organizations and Integrated Health Delivery Networks.

In the United States, a healthcare group purchasing organization (or GPO) is an entity that is created to leverage the purchasing power of a group of hospitals to obtain discounts from vendors based on the collective buying power of the GPO members. Group purchasing is used in many industries to purchase raw materials and supplies, but it is common practice in the health care industry.

The Oxyview Nasal Cannula has garnered a lot of attention at several conventions throughout the world. This showing captured the attention of many distributors who are interested in this new medical technology, opening the doors to the possibility that Oxyview will become available worldwide to patients outside of the United States by March of 2010. Ingen recently unveiled its latest in medical respiratory equipment; the new Oxyview Pulse Oximeter.

In 2010, the adult nasal cannula manufacturer plans to aggressively market its medical devices to hospitals. But Ingen's bold plans for growth don't end here. The company also hopes to work with distributors to make the Oxyview product line available worldwide beginning in March-2010. Recently, at the MEDICA convention in Germany, Ingen's showcase of Oxyview earned the company attention from multiple distributors that were on hand for the event.

"We look forward to working with Ken Kuiper of Medical Strategies International. Our plan is to capture the VA Hospital market with our expected GSA approval, and capture the commercial hospital market through GPO contracts. The Oxyview Nasal Cannula and the Oxyview Pulse Oximeter will be a great improvement to oxygen therapy in the hospital setting," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
I HAVE BEEN WATCHING THIS STOCK FOR A WHILE. GREAT NEWS LATELY. I HAVE MADE MONEY WITH THIS STOCK BEFORE. I TOOK A POSITION IN IT YESTERDAY. I THINK ITS TIME TO MAKE SOME MONEY AGAIN.